Nature's Sunshine Shares Fall Premarket After Shanghai Fosun Sells Stake

Dow Jones

Jun 26

By Colin Kellaher

Nature's Sunshine Products shares fell sharply in premarket trading Thursday after one of the nutritional supplements maker's biggest investors sold its stake at steep discount.

Nature's Sunshine said a secondary public offering of up to 2.85 million shares held by a unit of Shanghai Fosun Pharmaceutical was priced at $12 apiece, well below Wednesday's closing price of $14.84.

Shares of the Lehi, Utah, company were recently down 16% to $12.50 in premarket trading.

Fosun received the shares, representing a more than 15% stake in Nature's Sunshine, as part of a 2014 transaction that formed a pair of joint ventures in which Fosun held 20% interests.

Nature's Sunshine said it will be required to buy Fosun's stake in the ventures in connection with the offering, adding that it expects to fund the roughly $7 million purchase with cash on hand and drawings under its credit facility.

The company said it also may buy back up to $15 million worth of the shares Fosun is selling.

Write to Colin Kellaher at colin.kellaher@wsj.com

(END) Dow Jones Newswires

June 26, 2025 07:29 ET (11:29 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2546782734"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2546782734\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2546782734?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-26 19:29","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2546782734","market":"us","top_or_hot":-1,"title":"Nature's Sunshine Shares Fall Premarket After Shanghai Fosun Sells Stake","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Colin Kellaher \n</p>\n<pre>\n \n</pre>\n<p>\n  Nature's Sunshine Products shares fell sharply in premarket trading Thursday after one of the nutritional supplements maker's biggest investors sold its stake at steep discount. \n</p>\n<p>\n  Nature's Sunshine said a secondary public offering of up to 2.85 million shares held by a unit of Shanghai Fosun Pharmaceutical was priced at $12 apiece, well below Wednesday's closing price of $14.84. \n</p>\n<p>\n  Shares of the Lehi, Utah, company were recently down 16% to $12.50 in premarket trading. \n</p>\n<p>\n  Fosun received the shares, representing a more than 15% stake in Nature's Sunshine, as part of a 2014 transaction that formed a pair of joint ventures in which Fosun held 20% interests. \n</p>\n<p>\n  Nature's Sunshine said it will be required to buy Fosun's stake in the ventures in connection with the offering, adding that it expects to fund the roughly $7 million purchase with cash on hand and drawings under its credit facility. \n</p>\n<p>\n  The company said it also may buy back up to $15 million worth of the shares Fosun is selling. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 26, 2025 07:29 ET (11:29 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nature's Sunshine Shares Fall Premarket After Shanghai Fosun Sells Stake</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNature's Sunshine Shares Fall Premarket After Shanghai Fosun Sells Stake\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-06-26 19:29</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Colin Kellaher \n</p>\n<pre>\n \n</pre>\n<p>\n  Nature's Sunshine Products shares fell sharply in premarket trading Thursday after one of the nutritional supplements maker's biggest investors sold its stake at steep discount. \n</p>\n<p>\n  Nature's Sunshine said a secondary public offering of up to 2.85 million shares held by a unit of Shanghai Fosun Pharmaceutical was priced at $12 apiece, well below Wednesday's closing price of $14.84. \n</p>\n<p>\n  Shares of the Lehi, Utah, company were recently down 16% to $12.50 in premarket trading. \n</p>\n<p>\n  Fosun received the shares, representing a more than 15% stake in Nature's Sunshine, as part of a 2014 transaction that formed a pair of joint ventures in which Fosun held 20% interests. \n</p>\n<p>\n  Nature's Sunshine said it will be required to buy Fosun's stake in the ventures in connection with the offering, adding that it expects to fund the roughly $7 million purchase with cash on hand and drawings under its credit facility. \n</p>\n<p>\n  The company said it also may buy back up to $15 million worth of the shares Fosun is selling. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 26, 2025 07:29 ET (11:29 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NATR","symbol_name":"天然阳光产品","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2546782734","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2546782734","pubTimestamp":1750937340,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Nature's Sunshine Products shares fell sharply in premarket trading Thursday after one of the nutritional supplements maker's biggest investors sold its stake at steep discount.Nature's Sunshine said a secondary public offering of up to 2.85 million shares held by a unit of Shanghai Fosun Pharmaceutical was priced at $12 apiece, well below Wednesday's closing price of $14.84.Shares of the Lehi, Utah, company were recently down 16% to $12.50 in premarket trading.Fosun received the shares, representing a more than 15% stake in Nature's Sunshine, as part of a 2014 transaction that formed a pair of joint ventures in which Fosun held 20% interests.Nature's Sunshine said it will be required to buy Fosun's stake in the ventures in connection with the offering, adding that it expects to fund the roughly $7 million purchase with cash on hand and drawings under its credit facility.The company said it also may buy back up to $15 million worth of the shares Fosun is selling.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"600196":"复星医药","NATR":"天然阳光产品","BK0028":"国家队","BK1191":"制药","00509":"世纪阳光(新)","BK0175":"白马股","BK1593":"医美概念股","BK0060":"抗癌","BK1230":"工业集团企业","BK1515":"抗疫概念","BK0196":"行业龙头","00656":"复星国际","BK0239":"医药制造","BK0187":"一线龙头","BK0096":"民营医院","BK1543":"农业股票概念","BK1113":"化肥与农用药剂","BK0183":"MSCI概念","BK0188":"融资融券","BK4183":"个人用品","BK0012":"证金概念","02196":"复星医药"},"translate_title":"上海复星出售股份后，大自然阳光股价盘前下跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600196":0.9,"00509":1,"00656":1,"02196":0.9,"NATR":0.9},"content_text":"By Colin Kellaher \n\n\n \n\n\n  Nature's Sunshine Products shares fell sharply in premarket trading Thursday after one of the nutritional supplements maker's biggest investors sold its stake at steep discount. \n\n\n  Nature's Sunshine said a secondary public offering of up to 2.85 million shares held by a unit of Shanghai Fosun Pharmaceutical was priced at $12 apiece, well below Wednesday's closing price of $14.84. \n\n\n  Shares of the Lehi, Utah, company were recently down 16% to $12.50 in premarket trading. \n\n\n  Fosun received the shares, representing a more than 15% stake in Nature's Sunshine, as part of a 2014 transaction that formed a pair of joint ventures in which Fosun held 20% interests. \n\n\n  Nature's Sunshine said it will be required to buy Fosun's stake in the ventures in connection with the offering, adding that it expects to fund the roughly $7 million purchase with cash on hand and drawings under its credit facility. \n\n\n  The company said it also may buy back up to $15 million worth of the shares Fosun is selling. \n\n\n \n\n\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 26, 2025 07:29 ET (11:29 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}